Pregnancy outcomes in women receiving growth hormone replacement therapy enrolled in the NordiNet® International Outcome Study (IOS) and the American Norditropin® Studies: Web-Enabled Research (ANSWER) Program – Biller et al. (Pituitary, 2021)

Pregnancy outcomes in women receiving growth hormone replacement therapy enrolled in the NordiNet® International Outcome Study (IOS) and the American Norditropin® Studies: Web-Enabled Research (ANSWER) Program – Biller et al. (Pituitary, 2021)

This analysis of pregnancy outcomes in women receiving growth hormone is based on the pooled analysis of the NordiNet IOS (Europe) and ANSWER (US) Paediatric Growth Hormone Programs. Qualiance (Acknowledgement) provided statistical support to produce the underlying...